Indegene launches Invisage, an AI-enabled hybrid omnichannel sales and marketing platform to improve HCP impact for life sciences companies
Retrieved on:
Tuesday, August 22, 2023
PRINCETON, N.J., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company today announced the launch of Invisage [in-vis-ij], an AI-enabled proprietary platform to help life sciences organizations optimize their go-to-market model.
Key Points:
- PRINCETON, N.J., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company today announced the launch of Invisage [in-vis-ij], an AI-enabled proprietary platform to help life sciences organizations optimize their go-to-market model.
- Invisage helps deliver personalized outcomes to healthcare professionals (HCPs) by leveraging data from over 2 million HCP and more than 200 million HCP interactions.
- Invisage is an integrated hybrid omnichannel platform that brings together data, AI-driven scientific modeling, and strategic insights to deploy digital campaigns and partner digital channels with a sales force to expand HCP reach and optimize interactions.
- “We are excited to introduce Invisage to the market and enable life sciences companies to effectively reach HCPs, powered by Indegene’s AI-driven platform and our team of experts,” said Nancy Phelan, Senior Vice President, Omnichannel Activation, Indegene.